Page last updated: 2024-12-05

1-phenylpropanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-Phenylpropanol, also known as hydrocinnamyl alcohol, is a colorless liquid with a sweet, floral scent. It is a common ingredient in perfumes and fragrances. It can be synthesized through various methods, including the reduction of cinnamaldehyde with sodium borohydride or by Grignard reaction of benzaldehyde with propyl magnesium bromide. 1-Phenylpropanol is a chiral molecule and exists as two enantiomers. Its applications extend beyond fragrance, with potential as an intermediate in the synthesis of pharmaceuticals and other fine chemicals. It is studied for its biological activities, including its antioxidant and anti-inflammatory properties. The compound exhibits a moderate level of toxicity and can cause skin and eye irritation.'

1-phenylpropanol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7147
CHEMBL ID1397202
CHEBI ID31995
SCHEMBL ID56673
MeSH IDM0405079

Synonyms (116)

Synonym
s-(-)-1-phenylpropanol
nsc41708
nsc-41708
bilergon
felitrope
phenyl ethyl carbinol
carbicol
.alpha.-ethylbenzyl alcohol
nsc25504
1-phenyl-1-propanol
benzyl alcohol, .alpha.-ethyl-
.alpha.-hydroxypropylbenzene
.omega.-ethylbenzyl alcohol
gallenperlen
phenylchol
choleda
nsc-25504
sh 261
felicur
phenicol
phenycholon
benzenemethanol, .alpha.-ethyl-
livonal
epatoxfen
1-phenylpropyl alcohol
1-phenyl-1-hydroxypropane
phenychol
fepar
unichol
1-propanol, 1-phenyl-
ethyl phenyl carbinol
ejibil
fenicol (van)
ai3-19819
benzenemethanol, alpha-ethyl-
phenylaethylcarbinol [german]
alpha-hydroxypropylbenzene
benzyl alcohol, alpha-ethyl-
einecs 202-256-0
nsc 25504
brn 1906759
phenylcholon
fema no. 2884
1-phenylpropanol
phenylpropanol [jan]
alpha-ethylbenzenemethanol
alpha-ethylbenzyl alcohol
phenylpropanol
r-(+)-1-phenylpropanol
alpha-ethyl-benzyl alcohol
1-phenylpropan-1-ol
ethylphenylcarbinol
93-54-9
GHL.PD_MITSCHER_LEG0.415
1-phenyl-1-propanol, >=97%, fg
NCGC00166078-01
NCGC00165980-01
NCGC00165972-01
D01470
phenylpropanol (jan)
1-phenyl-1-propanol, >=97%
ethylbenzyl alcohol
AKOS000249117
P0212
1-phenyl-propan-1-ol
unii-0f897o3o4m
ec 202-256-0
0f897o3o4m ,
4-06-00-03183 (beilstein handbook reference)
phenylaethylcarbinol
cas-93-54-9
tox21_112275
dtxcid0024474
dtxsid2044474 ,
FT-0605087
FT-0608230
FT-0605196
S11247
CHEMBL1397202
ethylbenzyl alcohol [who-dd]
phenylpropanol [inci]
1-phenyl-1-propanol [fhfi]
phenylpropanol [mart.]
.alpha.-ethylbenzyl alcohol [mi]
SCHEMBL56673
1-hydroxy-1-phenylpropane
phenyl propanol
1- phenyl-1-propanol
(+/-) 1-phenyl-1-propanol
a-ethylbenzyl alcohol
AKOS016843880
Q-200134
STR02714
.alpha.-ethylbenzenemethanol
phenyl-1-propan-1-ol
1-phenyl-n-propanol
mfcd00004564
sr-01000944521
SR-01000944521-1
CHEBI:31995
phenylpropylalkohol
a-hydroxypropylbenzene
other proprietary names
fema 2884
a-ethylbenzenemethanol, 9ci
Q15726117
EN300-128217
SY020321
AMY40852
NCGC00165972-02
AB88253
SY101126
CS-W013334
HY-W012618
(+/-)-1-phenylpropanol
Z335245178

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organic molecular entityAny molecular entity that contains carbon.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency8.91250.003245.467312,589.2998AID2517
lamin isoform A-delta10Homo sapiens (human)Potency0.39810.891312.067628.1838AID1487
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (300)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (3.67)18.7374
1990's0 (0.00)18.2507
2000's60 (20.00)29.6817
2010's196 (65.33)24.3611
2020's33 (11.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.91 (24.57)
Research Supply Index5.72 (2.92)
Research Growth Index6.47 (4.65)
Search Engine Demand Index39.89 (26.88)
Search Engine Supply Index1.83 (0.95)

This Compound (33.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews19 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other285 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]